Mizuho Securities USA’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Mizuho Securities USA’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-674,829	Closed	-$7.27M	–	258
2023 Q3	$7.27M	Sell	674,829 -339,505	-33%	-$3.64M	0.22%	22
2023 Q2	$10.7M	Buy	+1,014,334	New	+$10.7M	0.36%	14

Mizuho Securities USA's BIOS Position: Q4 2023 in Review

Mizuho Securities USA sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 674,829 shares — an estimated $7.27M sold.

Mizuho Securities USA first reported a position in BIOS in Q2 2023 and held it in 2 quarters. The position peaked at $10.7M in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Mizuho Securities USA reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Mizuho Securities USA sold 674,829 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $7.27M.
Mizuho Securities USA first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q2 2023 and held it in 2 quarters.
Mizuho Securities USA's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $10.7M in Q2 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Mizuho Securities USA's 13F filing for Q4 2023, filed 8 Feb 2024.